Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are using a tumor organoid system to examine the effects of metabolites secreted by bacteria on a specialized immunotherapy—immune checkpoint blockage, ...
Jul 29, 2022
0
57
When cancer cells break away from the original tumor in metastatic—stage IV—breast cancer, they usually spread to the bones, liver or lungs. A new study, associated with the MetEpiStem project, describes what happens ...
Jul 13, 2022
0
39
PIK3CA is a gene that makes an enzyme called PI3K, which is involved in many important cell functions. When PIK3CA mutates, however, it can make the PI3K enzyme become overactive and cause cancer cells to grow.
Jul 8, 2022
0
71
Worldwide, breast cancer (BC) is the second most common cancer. Pharmacologically targeting cyclin-dependent kinase 4 and 6 (CDK4 & 6) has proven to be a successful therapeutic approach in patients with estrogen receptor-positive ...
Jul 6, 2022
0
6
Two new innovations could make it easier for doctors to decipher when cancers that impact women are present and need urgent attention:
Jul 6, 2022
0
4
Having a baby after breast cancer does not negatively impact a woman's chance of surviving the disease. A new study shows that survival is no worse in younger women, those who had not been pregnant before, and those with ...
Jul 5, 2022
0
19
Progress towards a unique vaccine targeting specific breast cancer antigens has been shown to delay tumor growth and prevent breast cancer metastasis in preclinical models in a study led by the Malaghan Institute of Medical ...
Jul 5, 2022
0
11
The treatment of breast cancer abounding in the protein HER2 was revolutionized with the introduction of drugs like trastuzumab (Herceptin) that target the protein. When researchers discovered that breast cancers with lower ...
Jun 24, 2022
0
8
A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can accurately detect the presence of cancer DNA in the blood of patients with metastatic breast cancer within ...
Jun 23, 2022
0
26
Antibody therapies are offering promising treatment breakthroughs for cancer and other illnesses, generating greater investor interest more than 20 years after they were first commercialized.
Jun 22, 2022
0
52
